BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 32276105)

  • 1. Weighted gene co-expression network analysis reveals specific modules and biomarkers in Parkinson's disease.
    Jin X; Li J; Li W; Wang X; Du C; Geng Z; Geng Y; Kang L; Zhang X; Wang M; Tian S
    Neurosci Lett; 2020 May; 728():134950. PubMed ID: 32276105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying the hub gene and immune infiltration of Parkinson's disease using bioinformatical methods.
    Liu SH; Wang YL; Jiang SM; Wan XJ; Yan JH; Liu CF
    Brain Res; 2022 Jun; 1785():147879. PubMed ID: 35278479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weighted gene co-expression network analysis identifies specific modules and hub genes related to Parkinson's disease.
    Yang M; Wu XQ; Ding CB; Zhang GF; Li M; Lv LN; Li YH; Sun DW; Zhao JJ
    Neuroreport; 2021 Sep; 32(13):1073-1081. PubMed ID: 34284443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative analysis of potential biomarkers and immune cell infiltration in Parkinson's disease.
    Chen X; Cao W; Zhuang Y; Chen S; Li X
    Brain Res Bull; 2021 Dec; 177():53-63. PubMed ID: 34536521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Integrated Network Analysis of mRNA and Gene Expression Profiles in Parkinson's Disease.
    Wang Y; Wang Z
    Med Sci Monit; 2020 Mar; 26():e920846. PubMed ID: 32210219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative analysis of gene expression profiles of substantia nigra identifies potential diagnosis biomarkers in Parkinson's disease.
    Huang J; Li B; Wei H; Li C; Liu C; Mi H; Chen S
    Sci Rep; 2024 Jan; 14(1):2167. PubMed ID: 38272954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Six potential biomarkers in septic shock: a deep bioinformatics and prospective observational study.
    Kong C; Zhu Y; Xie X; Wu J; Qian M
    Front Immunol; 2023; 14():1184700. PubMed ID: 37359526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of Parkinson's disease marker-based weighted protein-protein interaction network for prioritization of co-expressed genes.
    George G; Valiya Parambath S; Lokappa SB; Varkey J
    Gene; 2019 May; 697():67-77. PubMed ID: 30776463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of key genes and pathways in Parkinson's disease through integrated analysis.
    Wang J; Liu Y; Chen T
    Mol Med Rep; 2017 Oct; 16(4):3769-3776. PubMed ID: 28765971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of potential genomic biomarkers for Parkinson's disease using data pooling of gene expression microarrays.
    Lin Z; Zhou L; Li Y; Liu S; Xie Q; Xu X; Wu J
    Biomark Med; 2021 Jun; 15(8):585-595. PubMed ID: 33988461
    [No Abstract]   [Full Text] [Related]  

  • 11. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of key pathogenic genes of sepsis based on the Gene Expression Omnibus database.
    Lu X; Xue L; Sun W; Ye J; Zhu Z; Mei H
    Mol Med Rep; 2018 Feb; 17(2):3042-3054. PubMed ID: 29257295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic mechanisms and potential therapeutic targets for Parkinson disease revealed by bioinformatic analysis of necroptosis and immune cell infiltration.
    Lin Z; Zhang J; Wu R; Chen G; Peng J; Li R; Chen S
    Medicine (Baltimore); 2023 Sep; 102(39):e35311. PubMed ID: 37773866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weighted gene co-expression network analysis revealed key biomarkers associated with the diagnosis of hypertrophic cardiomyopathy.
    Li X; Wang C; Zhang X; Liu J; Wang Y; Li C; Guo D
    Hereditas; 2020 Oct; 157(1):42. PubMed ID: 33099311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of potential immune-related hub genes in Parkinson's disease based on machine learning and development and validation of a diagnostic classification model.
    Xin G; Niu J; Tian Q; Fu Y; Chen L; Yi T; Tian K; Sun X; Wang N; Wang J; Zhang H; Wang L
    PLoS One; 2023; 18(12):e0294984. PubMed ID: 38051734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of hub gene associated with the infection of Staphylococcus aureus via weighted gene co-expression network analysis.
    Li JX; Cao XJ; Huang YY; Li YP; Yu ZY; Lin M; Li QY; Chen JC; Guo XG
    BMC Microbiol; 2021 Dec; 21(1):329. PubMed ID: 34852788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-expression modules construction by WGCNA and identify potential hub genes and regulation pathways of postpartum depression.
    Deng Z; Cai W; Liu J; Deng A; Yang Y; Tu J; Yuan C; Xiao H; Gao W
    Front Biosci (Landmark Ed); 2021 Nov; 26(11):1019-1030. PubMed ID: 34856750
    [No Abstract]   [Full Text] [Related]  

  • 18. The identification and verification of hub genes associated with pulmonary arterial hypertension using weighted gene co-expression network analysis.
    Wu W; Chen A; Lin S; Wang Q; Lian G; Luo L; Xie L
    BMC Pulm Med; 2022 Dec; 22(1):474. PubMed ID: 36514015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and Experimental Validation of Parkinson's Disease with Major Depressive Disorder Common Genes.
    Wang H; Dou S; Wang C; Gao W; Cheng B; Yan F
    Mol Neurobiol; 2023 Oct; 60(10):6092-6108. PubMed ID: 37418066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Key Genes and Immunological Features Associated with Copper Metabolism in Parkinson's Disease by Bioinformatics Analysis.
    Zhang H; Nagai J; Hao L; Jiang X
    Mol Neurobiol; 2024 Feb; 61(2):799-811. PubMed ID: 37659036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.